Issued April 6, 2011 Approval Order Summary Labeling Other Consumer Information This document is in a Portable Document Format (PDF). Acrobat Reader is required to read this document. Updated April 20, 2011
GLASSIA
<!– –> <!– Page Last Updated: 04/20/2011 –> Page Last Updated: 04/20/2011 <!– –> Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Communicating Drug Safety Messages
<!– –> <!– Page Last Updated: 04/20/2011 –> Page Last Updated: 04/20/2011 <!– –> Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Medical Device Data Systems
<!– –> <!– Page Last Updated: 04/19/2011 –> Page Last Updated: 04/19/2011 <!– –> Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Steris System 1 Processor: 6 Month Extension for Healthcare Facilities To Transition to Legally-Marketed Alternatives
<!– –> <!– Page Last Updated: 04/19/2011 –> Page Last Updated: 04/19/2011 <!– –> Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
FDA Drug Safety Communication: Drug labels now contain updated recommendations on the appropriate use of long-acting inhaled asthma medications called Long-Acting Beta-Agonists (LABAs)
<!– –> <!– Page Last Updated: 04/15/2011 –> Page Last Updated: 04/15/2011 <!– –> Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
FDA Drug Safety Communication: FDA requires post-market safety trials for Long-Acting Beta-Agonists (LABAs)
<!– –> <!– Page Last Updated: 04/15/2011 –> Page Last Updated: 04/15/2011 <!– –> Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Topamax (topiramate): Recall
<!– –> <!– Page Last Updated: 04/15/2011 –> Page Last Updated: 04/15/2011 <!– –> Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Lansoprazole Delayed-Release Orally Disintegrating Tablets by Teva Pharmaceuticals: Letter to Healthcare Professionals
<!– –> <!– Page Last Updated: 04/15/2011 –> Page Last Updated: 04/15/2011 <!– –> Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Long-Acting Beta-Agonists (LABAs): New Safe Use Requirements
<!– –> <!– Page Last Updated: 04/15/2011 –> Page Last Updated: 04/15/2011 <!– –> Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.